Skip to content
Shasqi logo

Shasqi

Shasqi is a YC Winter 2015 (W15) company. Based in San Francisco, CA, USA; Remote. Team of 28.

  • Biotech
  • Therapeutics

About Shasqi

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

Shasqi develops cancer therapeutics using its CAPAC platform, which applies click chemistry to activate treatment directly at the tumor site. A click chemistry reagent is localized in the tumor; when a systemically infused prodrug reaches it, the two react and release an active therapy at the target. This confines the therapeutic effect to the tumor while holding systemic exposure below toxic levels, replacing the blunt-force toxicity of conventional chemotherapy.

From the Y Combinator listing

How Shasqi describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Targeting Cancer with Click Chemistry

Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
San Francisco, CA, USA; Remote
Team size
28
Status
Active
Stage
Growth

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works